Emily Fukuchi, MD; Barbara Fetterman, SCT (ASCP); Nancy Poitras, ACS, PMP; Walter Kinney, MD; Thomas Lorey, MD; Ramey D. Littell, MD To evaluate whether the presence of CIN 1 on ECC contributes to ...

Cervical intraepithelial neoplasia (CIN), also ... Treatment may not be necessary in cases of low-grade CIN 1 because the underlying infection often resolves on its own. For higher-grade disease ...

Here are 5 important questions to ask if you’ve been told you have cervical dysplasia: ...

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive cervical intraepithelial neoplasia grade 3 (CIN3), according to results from ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

grade 1, grade 2, and grade 3 anal intraepithelial neoplasia (AIN). "The approval of GARDASIL for use in males 9-26 years old in China is a significant step forward in advancing public health ...

The investigators assessed the efficacy of the vaccine against cervical intraepithelial neoplasia grade 2+ (CIN2+) lesions ... or a control vaccine at 0, 1 and 6 months; of these women, 92% ...

The Papanicolaou (Pap) smear is commonly used to screen for cervical cancer and ... Administration to screen for high-grade cervical intraepithelial neoplasia. Women with positive test results ...

The proportions of women with CIN 2+ and CIN 3+ on excisional procedure within 24 months of CIN 1 cervical biopsy were calculated with binomial exact CIs.